Navigation Links
Insight Accelerator Labs Advances Member Toward Commercialization

Chicago, IL (PRWEB) July 31, 2014

Insight Accelerator Labs member PhysIQ (formerly known as VGBio) has completed a Series A round of investment for $4.6 million to fund the continued development of its innovative wearable device for collecting vital signs. The company joined Insight Accelerator Labs in 2012 to bring their healthcare technology to fruition with the help of Insight development teams.

“PhysIQ’s recent funding milestone underscores our reason for launching the Accelerator,” says Steve McPhilliamy, Executive Director of Insight Accelerator Labs. “There are without question, a finite number of product innovation opportunities in the medical space. Even the most inventive, life-enhancing products can fail to see their full market potential without seasoned development resources and strong support in the medical realm.”

PhysIQ is the first patient-centered analytics platform for both the regulated Healthcare and unregulated Health & Fitness markets. The PhysIQ platform constructs a personalized baseline norm for each person monitored, rather than simple trending or comparison to population-based statistics.

“Our series A funding is a testament to Insight Accelerator Labs’ value to us as a start-up,” says Gary Conkright, CEO of PhysIQ. “The end-to-end innovation support and leverage we received from Insight - from product strategy, to long-range scaling and technical development to production - made it possible for us to exceed our aggressive development timelines and navigate the medical domain. The success we’ve experienced to date would not have been possible otherwise.”

Insight worked closely with PhysIQ to develop its patient wearable device, VitaLink - which enables continuous monitoring of patients with chronic diseases, that enables clinicians to provide proactive treatment. Featuring a body worn sensor network, the device collects patient vital signs and utilizes proprietary personalized analytics to identify changes in physiology that could be early signs of an exacerbation.

The wearable sensor system of the VitaLink remote patient monitoring solution was developed with Insight as part of a contract physIQ had with US Department of Veteran Affairs, Center for Innovation. The product is currently part of two internal review board approved clinical studies; one with the Veterans Administration and a second with the University of Chicago Medical Center. The recent Series A funding is the first of several expected by the company to further expand the technology’s scale and advance its commercialization.

About Insight Accelerator Labs

Insight Accelerator Lab (IAL) is the first medical device accelerator in the Midwestern United States. Founded in 2013 by design innovation consultancy Insight, the company partners with top healthcare entrepreneurs to develop innovative medical device technologies that will have a positive impact on people’s lives. IAL’s organizational mission is helping its member companies successfully overcome the hurdles inherent to the complex, long-cycle medical device development ecosystem that so commonly prevent life-improving innovation from making it to market. For up to 18 months, start-up medical device companies that participate in the program receive expert mentoring, product development services, grant and award application assistance and extensive infrastructure support from Insight’s development teams from product ideation toward the ultimate commercialization of their products. For more information, visit

Read the full story at

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. From a Failed Vaccine, New Insights Into Fighting HIV
2. Clinical insight improves treatment with new lung cancer drug
3. New insights into when beach sand may become unsafe for digging and other contact
4. How does the immune system fight off threats to the brain? New research yields fresh insight
5. Understanding and promoting mental health - Insights from psychological science
6. Aggregating instead of stabilizing: New insights into the mechanisms of heart disease
7. Cancer Patients Share Web Info With Docs for Insight, Advice
8. Drug addiction study offers new insight on compulsive behavior
9. Better treatment for brain cancer revealed by new molecular insights
10. Scientists at the Mainz University Medical Center gain new insights into Taspase1 function
11. Feces fossils lend new insights into connection between Native-Americans, diabetes
Post Your Comments:
(Date:11/25/2015)... ... 25, 2015 , ... Lakeview Health, a Jacksonville-based drug and ... sobriety and show through pictures what a positive difference it makes. The social ... the hashtag #FacesOfGratitude on their Facebook, Twitter, and Instagram accounts. Short stories ...
(Date:11/25/2015)... , ... November 25, 2015 , ... The McHenry County ... recent successful appellate decision obtained by Attorneys Francisco J. Botto and Alex C. Wimmer. ... Illinois Workers’ Compensation Comm’n, 2015 IL App (2d) 130884WC. , According to court documents, ...
(Date:11/25/2015)... ... November 25, 2015 , ... Beddit® has launched a new Android ... The new app features a more intuitive SleepScore™ that rates sleep quality on a ... The SleepScore is created by a proprietary algorithm. Beddit analyzes the data to provide ...
(Date:11/25/2015)... ... November 25, 2015 , ... Today, Mothers Against Drunk Driving (MADD) ... below 10,000 for the first time since 2011. In 2014, there were 9,967 fatalities ... released by the National Highway Traffic Safety Administration (NHTSA), 32,675 people were killed in ...
(Date:11/25/2015)... ... 2015 , ... Privately owned Contract Development and Manufacturing Organization ... current state of the art research, development and manufacturing facility outside of Fort ... capacity as well as to support its clients’ growing research and development and ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... 25, 2015 On Tuesday, November 24, ... trial against Wright Medical Technology, Inc. for product ... metal-on-metal hip implant device, awarded $11 million in ... week trial and three days of deliberations, the ... was defectively designed and unreasonably dangerous, and that ...
(Date:11/25/2015)... 25, 2015 Kitov Pharma ... KTOV), a biopharmaceutical company focused on the development of ... conditions, today announced the closing of its previously announced ... ADSs ), each representing 20 ordinary shares of the ... The ADSs and warrants were issued in a fixed ...
(Date:11/25/2015)... DIEGO , Nov. 25, 2015  Today AVACEN Medical announced the issue of ... Thermal Energy Including Blood Viscosity Adjustment ". This patent shields the company,s AVACEN 100 dry heat ... Treatment Method. Photo - ... ... ...
Breaking Medicine Technology: